Many reports have implicated that the PGRMC1 expressed predominantly in human liver, ovary, and kidney tissue, and is known to be over-expressed in various types of cancers, including breast cancer, head and neck cancer, ovarian cancer, and lung cancer (Kabe et al., 2016, 2018; Kim et al., 2019). Here, PGRMC1 is linked to head and neck cancer.